Herbalife (HLF) Competitors

Prestige Consumer Healthcare (NYSE:PBH) and Herbalife (NYSE:HLF) are both personal products companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

Do analysts rate PBH or HLF?

Prestige Consumer Healthcare presently has a consensus target price of $93.33, indicating a potential upside of 43.46%. Herbalife has a consensus target price of $11.50, indicating a potential upside of 19.92%. Given Prestige Consumer Healthcare's higher possible upside, equities analysts clearly believe Prestige Consumer Healthcare is more favorable than Herbalife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Herbalife	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Do institutionals and insiders believe in PBH or HLF?

100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 1.4% of Prestige Consumer Healthcare shares are held by company insiders. Comparatively, 1.7% of Herbalife shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more risk and volatility, PBH or HLF?

Prestige Consumer Healthcare has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Herbalife has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Does the media favor PBH or HLF?

In the previous week, Prestige Consumer Healthcare had 6 more articles in the media than Herbalife. MarketBeat recorded 14 mentions for Prestige Consumer Healthcare and 8 mentions for Herbalife. Herbalife's average media sentiment score of 0.79 beat Prestige Consumer Healthcare's score of 0.44 indicating that Herbalife is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Herbalife	2 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, PBH or HLF?

Herbalife has higher revenue and earnings than Prestige Consumer Healthcare. Herbalife is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.14B	2.81	$214.60M	$4.26	15.27
Herbalife	$4.99B	0.20	$254.30M	$3.17	3.03

Is PBH or HLF more profitable?

Prestige Consumer Healthcare has a net margin of 19.02% compared to Herbalife's net margin of 6.59%. Prestige Consumer Healthcare's return on equity of 12.69% beat Herbalife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	19.02%	12.69%	6.79%
Herbalife	6.59%	-27.36%	7.97%

Summary

Prestige Consumer Healthcare beats Herbalife on 8 of the 15 factors compared between the two stocks.